Basket cover image
15 handpicked stocks

Cleared For Takeoff: Airlines Set To Gain From Rival's Disruption

Air Canada flight attendants have overwhelmingly voted to authorize a strike, creating significant operational risk for the airline. This potential disruption could divert a flood of passengers to competing carriers, creating a tactical investment opportunity in rival airlines.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at अगस्त 6

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

UAL

United Continental Holdings, Inc.

UAL

Current price

$102.19

DAL

Delta Air Lines Inc.

DAL

Current price

$60.50

AAL

American Airlines Group Inc.

AAL

Current price

$13.22

About This Group of Stocks

1

Our Expert Thinking

This tactical opportunity stems from Air Canada's flight attendants voting overwhelmingly to authorise a strike. A work stoppage during peak travel season could ground the airline and create a ripple effect across North American aviation, with competing carriers positioned to absorb displaced passengers and boost revenue.

2

What You Need to Know

This is an event-driven investment theme focused on airlines with significant route overlap to Air Canada. These carriers operate extensive networks that can quickly absorb increased demand, potentially improving load factors and near-term financial performance during a competitor's operational disruption.

3

Why These Stocks

These airlines were handpicked by professional analysts based on their ability to capture market share from Air Canada's potential disruption. The selection focuses on carriers in the Americas with overlapping routes and operational capacity to benefit from a sudden influx of passengers seeking alternative travel options.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+28.52%

Group Performance Snapshot

28.52%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 28.52% over the next year.

11 of 14

Stocks Rated Buy by Analysts

11 of 14 assets in this group are rated Buy by professional analysts.

7.2% vs 4%

Group Growth vs Bank interest

This group averaged a 7.2% return last month, beating the typical 4% bank rate.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

✈️

Strike Deadline Approaching

Air Canada's flight attendants could legally halt work as early as mid-August, right during peak travel season. This timing creates immediate urgency for passengers to find alternative carriers.

📈

Instant Market Share Gains

When a major airline goes offline, competing carriers can quickly absorb displaced passengers and boost their load factors. This translates directly into increased revenue and potentially higher stock prices.

🎯

Tactical Opportunity Window

This event-driven situation offers a clear, time-sensitive investment opportunity. Airlines with overlapping routes are positioned to benefit immediately from Air Canada's operational challenges.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All Stock Groups

Frequently Asked Questions

Everything you need to know about the product and billing.